Has Sydney Montesi, MD received payments from drug or device companies?

Yes. Drug and device makers reported $3,495 in general payments to Sydney Montesi, MD across 4 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Sydney Montesi, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Sydney Montesi, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Sydney Montesi, MD

Internal Medicine · Boston, MANPI 1124287586

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $3,371 of the $3,495 with a category attached, or 96.5%. 3 manufacturers reported payments, led by Amgen at 56.4% of the total. Among internal medicine clinicians in MA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,495in general payments, 2019–2025

Across 4 payments — averaging $873.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Amgen$2K
Gilead$1K
AbbVie$46

$430,984in research payments, 2019–2025

Across 59 payments — averaging $7304.82 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Boehringer Ingelheim$325K
Merck$59K
United Therapeutics Corporation$21K
Siemens Medical Solutions USA, Inc.$13K
Roche Products Limited$11K
Hoffmann-la Roche Limited$2K
plus $975 from 1 others

What the payments were for

Consulting fees$3,37196%
Food & beverage$1244%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Amgen	1	$1,971
Gilead	2	$1,478
AbbVie	1	$46

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Tavneos$1,971

How this compares

$3,495 in reported general payments places this provider in the 90th percentile of 4,983 internal medicine providers in Massachusetts.

See all internal medicine providers in Massachusetts →

Medicare billing

Part B allowed, 2024

$15,493

Medicare patients

Services billed

109

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
OfevNintedanib Esylate	22	$260,328
Wixela InhubFluticasone Propion/Salmeterol	12	$615
Albuterol Sulfate HfaAlbuterol Sulfate	11	$180
Prednisone	17	$113

Paid to pharmacies, not to this prescriber.

Other internal medicine in Boston

David SchenkeinBoston$5M
John FallonBoston$1.8M
Michael MendelsohnBoston$1.6M
Gaurav SingalBoston$798K
Asit ParikhBoston$486K
Noopur RajeBoston$481K
Daniel KuritzkesBoston$443K
Xiuning leBoston$364K
Nancy GaglianoBoston$358K
Fatima StanfordBoston$285K

See the full list for Massachusetts →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →